Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England

Introduction Preliminary studies of artificial intelligence (AI) tools developed to support breast screening demonstrate the potential to reduce radiologist burden and improve cancer detection which could lead to improved breast cancer outcomes. This study explores the public acceptability of the us...

Full description

Saved in:
Bibliographic Details
Main Authors: Jo Waller, Rumana Newlands, Lauren Gatting, Angie A Kehagia, Syeda Ahmed, Priscilla Meccheri
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Public Health
Online Access:https://bmjpublichealth.bmj.com/content/2/2/e000892.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542165668986880
author Jo Waller
Rumana Newlands
Lauren Gatting
Angie A Kehagia
Syeda Ahmed
Priscilla Meccheri
author_facet Jo Waller
Rumana Newlands
Lauren Gatting
Angie A Kehagia
Syeda Ahmed
Priscilla Meccheri
author_sort Jo Waller
collection DOAJ
description Introduction Preliminary studies of artificial intelligence (AI) tools developed to support breast screening demonstrate the potential to reduce radiologist burden and improve cancer detection which could lead to improved breast cancer outcomes. This study explores the public acceptability of the use of AI in breast screening from the perspective of screening-eligible women in England.Methods 64 women in England, aged 50–70 years (eligible for breast screening) and 45–49 years (approaching eligibility), participated in 12 focus groups—8 online and 4 in person. Specific scenarios in which AI may be used in the mammogram reading process were presented. Data were analysed using a reflexive thematic analysis.Results Four themes described public perceptions of AI in breast screening found in this study: (1) Things going wrong and being missed summarises a predominant and pervasive concern about an AI tool being used in breast screening; (2) Speed of change and loss of control captures a positive association of AI with technological advances held by the women but also feelings of things being out of their control, and that they were being left behind and in the dark; (3) The importance of humans reports concern around the possibility that AI excludes humans and renders them redundant and (4) Desire for thorough research, staggered implementation and double-checking of scans included insistence that any AI be thoroughly trialled, tested and not solely relied on when initially implemented.Conclusions It will be essential that future decision-making and communication about AI implementation in breast screening (and, likely, in healthcare more widely) address concerns surrounding (1) the fallibility of AI, (2) lack of inclusion, control and transparency in relation to healthcare and technology decisions and (3) humans being left redundant and unneeded, while building on women’s hopes for the technology.
format Article
id doaj-art-4b210455bcd04baa98fc3b4bed5738f9
institution Kabale University
issn 2753-4294
language English
publishDate 2024-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Public Health
spelling doaj-art-4b210455bcd04baa98fc3b4bed5738f92025-02-04T08:15:10ZengBMJ Publishing GroupBMJ Public Health2753-42942024-12-012210.1136/bmjph-2024-000892Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in EnglandJo Waller0Rumana Newlands1Lauren Gatting2Angie A Kehagia3Syeda Ahmed4Priscilla Meccheri5Cancer Prevention Group, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UKHealth Services Research Unit, University of Aberdeen, Aberdeen, UKCancer Prevention Group, School of Cancer & Pharmaceutical Sciences, King`s College London, London, UKKing’s Technology Evaluation Centre, School of Biomedical Engineering and Imaging Sciences, King`s College London, London, UKSchool of Mental Health & Psychological Sciences, Institute of Psychiatry, Psychology & Neuroscience, King`s College London, London, UKSchool of Mental Health & Psychological Sciences, Institute of Psychiatry, Psychology & Neuroscience, King`s College London, London, UKIntroduction Preliminary studies of artificial intelligence (AI) tools developed to support breast screening demonstrate the potential to reduce radiologist burden and improve cancer detection which could lead to improved breast cancer outcomes. This study explores the public acceptability of the use of AI in breast screening from the perspective of screening-eligible women in England.Methods 64 women in England, aged 50–70 years (eligible for breast screening) and 45–49 years (approaching eligibility), participated in 12 focus groups—8 online and 4 in person. Specific scenarios in which AI may be used in the mammogram reading process were presented. Data were analysed using a reflexive thematic analysis.Results Four themes described public perceptions of AI in breast screening found in this study: (1) Things going wrong and being missed summarises a predominant and pervasive concern about an AI tool being used in breast screening; (2) Speed of change and loss of control captures a positive association of AI with technological advances held by the women but also feelings of things being out of their control, and that they were being left behind and in the dark; (3) The importance of humans reports concern around the possibility that AI excludes humans and renders them redundant and (4) Desire for thorough research, staggered implementation and double-checking of scans included insistence that any AI be thoroughly trialled, tested and not solely relied on when initially implemented.Conclusions It will be essential that future decision-making and communication about AI implementation in breast screening (and, likely, in healthcare more widely) address concerns surrounding (1) the fallibility of AI, (2) lack of inclusion, control and transparency in relation to healthcare and technology decisions and (3) humans being left redundant and unneeded, while building on women’s hopes for the technology.https://bmjpublichealth.bmj.com/content/2/2/e000892.full
spellingShingle Jo Waller
Rumana Newlands
Lauren Gatting
Angie A Kehagia
Syeda Ahmed
Priscilla Meccheri
Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England
BMJ Public Health
title Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England
title_full Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England
title_fullStr Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England
title_full_unstemmed Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England
title_short Acceptability of artificial intelligence in breast screening: focus groups with the screening-eligible population in England
title_sort acceptability of artificial intelligence in breast screening focus groups with the screening eligible population in england
url https://bmjpublichealth.bmj.com/content/2/2/e000892.full
work_keys_str_mv AT jowaller acceptabilityofartificialintelligenceinbreastscreeningfocusgroupswiththescreeningeligiblepopulationinengland
AT rumananewlands acceptabilityofartificialintelligenceinbreastscreeningfocusgroupswiththescreeningeligiblepopulationinengland
AT laurengatting acceptabilityofartificialintelligenceinbreastscreeningfocusgroupswiththescreeningeligiblepopulationinengland
AT angieakehagia acceptabilityofartificialintelligenceinbreastscreeningfocusgroupswiththescreeningeligiblepopulationinengland
AT syedaahmed acceptabilityofartificialintelligenceinbreastscreeningfocusgroupswiththescreeningeligiblepopulationinengland
AT priscillameccheri acceptabilityofartificialintelligenceinbreastscreeningfocusgroupswiththescreeningeligiblepopulationinengland